The Clinical Evaluation of Methylprednisolone on the Improvement of Postoperative Neurological Functions of Cervical Spondylotic Myelopathy

ZHANG Wenzhi,XU Lei,HU Yefeng,XU Xiang
DOI: https://doi.org/10.3969/j.issn.1008-6358.2008.05.032
2008-01-01
Abstract:Objective:To evaluate the clinical effects of perioperative administration of Methylprednisolone(MP) on the improvement of postoperative neurological functions of cervical spondylotic myelopathy(CSM).Methods:Sixty-two patients with CSM were divided into 2 groups according to application of MP or not in perioperation.32 patients in MP group were treated with MP 15min prior to decompression, with 1500mg or 2000mg according to weight within 15min.Then after 45min interval, sequenced with 2000mg MP in the following 23h; 30 patients in the control group were treated with intravenous dexamethasone 10mg 15min prior to decompression and then sequenced with intravenous dexamethasone 5mg in 20% mannital 250ml, Bid×3d.Neurological function improvement rates were evaluated according to the JOA scores[(postoperative JOA scores-preoperative JOA scores)/(17-preoperative JOA scores) ×100%] at 3d,7d,1month and 6 months postoperation in both groups. Results: There were no statistical difference of neurological function improvement rate between the two groups at 3 d post-operation(P>0.05). Neurological function improvement rate were (67.93±9.45)% in MP group and (48.77±8.86)% in the control group at 7d post-operation(P<0.05). Neurological function improvement rate 1were (74.25±7.56)%in MP group and (60.85±9.66)% in the control group at 1 month post-operation(P<0.05). Neurological function improvement rate were (83.26±9.54)% in MP group and(70.67±8.99)% in the control group at 6 month post-operation(P<0.05).Conclusion:Perioperative administration of MP in patients with CSM can improve operative security and neurological function recovery rate.
What problem does this paper attempt to address?